Topic Search

  1. Home
  2. Topics
  3. Novartis
Novartis

Novartis

Related articles from Independent.ie

  1. Independent.ie logo
    Elan pins its hopes on Tysabri as 17pc revenue rise beats forecasts
    Independent.ie 3 weeks ago

    The patient had previously used Tysabri.Mr Clerkin said yesterday that Elan had not liaised with Novartis on the...

  2. Independent.ie logo
    Novartis unsure on MS drug link to case
    Independent.ie 1 month ago

    Tysabri, a treatment sold by Irish firm Elan and US-based Biogen Idec. Tysabri is known to have caused the brain...

Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Novartis

Search news from around the web

  1. James Brown -- a Music Video Challenge Presented by Saatchi & Saatchi, in Association With Genero.tv and BUG -- Now Open for Entries
    MarketWire logo MarketWire 1 hour ago

    Challenge, including eligibility and how to enter go to: http://genero.tv/jamesbrown Saatchi & Saatchi is part of the Publicis Groupe, the 3rd largest communications holding company worldwide. Saatchi & Saatchi's Network clients include Diageo,... Full Article at MarketWire

  2. Novartis Q4 net dips 3 percent at Rs 33 cr
    Firstpost 4 hours ago

    Delhi: Drug firm Novartis India today said its net profit declined by 3.23 percent to Rs 32.9 crore for the fourth quarter ended 31 March 2012. The company had posted a net profit of Rs 34 crore during the same period of previous fiscal, Novartis India... Full Article at Firstpost

  3. AP Photo logo AP Photo 1 month ago
    COMMERCIAL PHOTO - In this image taken by AP Images for Novartis, Jamie Schanbaum, front, meningitis survivor and founder of The J.A.M.I.E. Group, and representatives of the National Meningitis Association join hands in Rockefeller Center to raise...

    COMMERCIAL PHOTO - In this image taken by AP Images for Novartis, Jamie Schanbaum, front, meningitis survivor and founder of The J.A.M.I.E. Group, and representatives of the National Meningitis Association join hands in Rockefeller Center to raise... View Photo »

  4. The European Commission has approved Signifor (pasireotide) for the treatment of adult patients with Cushing's disease for whom surgery is not an option or for whom surgery has failed
    – Novartis SOURCE: France 24 4 weeks ago
  5. R&D Trends: Depression - Clinical attrition driven by mature market conditions
    PR Newswire logo PR Newswire 4 hours ago

    Despite the heightened competition within the marketplace, an abundance of drugs remain in the pipeline.Understand key dynamics in the R&D pipeline for new depression therapiesBenchmark novel and existing therapies using the target product profile... Full Article at PR Newswire

  6. Why Buying 'Market Outperform' Zalicus At A Discount Is Savvy
    Seeking Alpha logo Seeking Alpha 6 hours ago

    Very recent proof of Novartis activity cited here. However, there is more exciting news. In April 2012 (unknown until revealed here), Novartis filed its fifth patent (that I've been able to find) using Zalicus' Chalice software. This patent verifies... Full Article at Seeking Alpha

  7. Novartis Q4 net dips 3 pc at Rs 33 cr
    MSN India 7 hours ago
    NULL

    Delhi, May 24 (PTI) Drug firm Novartis India today said its net profit declined by 3.23 per cent to Rs 32.9 crore for the fourth quarter ended March 31, 2012. The company had posted a net profit of Rs 34 crore during the same period of previous fiscal,... Full Article at MSN India

  8. AP Photo logo AP Photo 2 months ago
    East Hanover, NJ, [March 19, 2012] - Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease.

    East Hanover, NJ, [March 19, 2012] - Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease. View Photo »

  9. Including the initial acquisition payment plus potential additional regulatory milestone payments, the deal with Novartis could exceed $550 million
    SOURCE: Boston.com 2 weeks ago
  10. shame novartis management
    YouTube Logo YouTube Videos 1 month ago
  11. Novartis calls students to participate in BioCamp at Hyderabad from July 30
    PharmaBiz.com 10 hours ago

    India is conducting Novartis Biotechnology Leadership Camp (BioCamp) at Hyderabad from July 30 to August 1, 2012 and invited students to participate from 100 Indian universities. BioCamp is a pioneering seminar organized by Novartis that brings young,... Full Article at PharmaBiz.com

  12. 'BUY' or 'SELL' ideas from experts for Thursday, May 24
    Economic Times logo Economic Times 13 hours ago

    Important results to watch: Central Bank of India, Gujarat State Petronet Ltd, Jai Corp Ltd, JM Financials Ltd, Jyoti Ltd, Madras Cements Ltd, Max India Ltd, MCX Ltd, Novartis India Ltd, Reliance Power Ltd, Shasun Pharma Ltd, TVS Motor Company Ltd, Jet... Full Article at Economic Times

  13. Nifty seen opening higher; OMCs will be in focus
    Economic Times logo Economic Times 13 hours ago

    08:00 a.m. , Nifty India stock futures in Singapore were up 29.50 point at 4,835.00, indicating a positive opening in the domestic market. Important results to watch: Central Bank of India, Gujarat State Petronet Ltd, Jai Corp Ltd, JM Financials Ltd,... Full Article at Economic Times

Related photos

  1. COMMERCIAL PHOTO - In this image taken by AP Images for Novartis, Jamie Schanbaum, front, meningitis survivor and founder of The J.A.M.I.E. Group, and representatives of the National Meningitis Association join hands in Rockefeller Center to raise awareness on World Meningitis Day,...
  2. East Hanover, NJ, [March 19, 2012] - Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease.
  3. NEW YORK, NY - FEBRUARY 22: People demonstrate outside of offices associated with the Swiss pharmaceutical company Novartis on February 22, 2012 in New York City. In a case being closely watched by pharmaceutical companies across the globe, Novartis is taking India to court to stop the...
  4. BASEL, SWITZERLAND - OCTOBER 25: Employees talk in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.
  5. BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen as trade union members give information to employee on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net...
  6. BASEL, SWITZERLAND - OCTOBER 25: An employee looks down as he smokes in front of Novartis headquarters on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.
  7. BASEL, SWITZERLAND - OCTOBER 25: A general view of Novartis headquarters is seen on October 25, 2011 in Basel, Switzerland. Novarits announced today it will cut 2000 jobs despite posting a 7 percent increased third-quarter and a net profit of 2.49 billion USD.
  8. People stand in front of the entrance of a Novartis production site in Nyon, Switzerland, Tuesday, Oct. 25, 2011. Swiss pharmaceutical giant Novartis AG posted a 7 percent increase in third-quarter net profit Tuesday as it announced 2,000 job cuts in an effort to save US dollar 200...
  9. COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe, center, shakes hands with U.S. Army veterinarian Col. G.C. Ritchie after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn...

About this topic

Wikipedia

Novartis International AG (NYSE: NVS) is a multinational pharmaceutical company based in Basel, Switzerland that manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate... Full Article At Wikipedia.org

Search Independent.ie topics

Timeline of coverage

  1. Click to see all coverage from Apr 07, 2012
    1
    April 07, 2012
  2. Click to see all coverage from Apr 08, 2012
    1
    April 08, 2012
  3. Click to see all coverage from Apr 09, 2012
    5
    April 09, 2012
  4. Click to see all coverage from Apr 10, 2012
    2
    April 10, 2012
  5. Click to see all coverage from Apr 11, 2012
    4
    April 11, 2012
  6. Click to see all coverage from Apr 12, 2012
    4
    April 12, 2012
  7. Click to see all coverage from Apr 13, 2012
    14
    April 13, 2012
  8. Click to see all coverage from Apr 14, 2012
    2
    April 14, 2012
  9. Click to see all coverage from Apr 15, 2012
    1
    April 15, 2012
  10. Click to see all coverage from Apr 16, 2012
    4
    April 16, 2012
  11. Click to see all coverage from Apr 17, 2012
    2
    April 17, 2012
  12. Click to see all coverage from Apr 18, 2012
    2
    April 18, 2012
  13. Click to see all coverage from Apr 19, 2012
    14
    April 19, 2012
  14. Click to see all coverage from Apr 20, 2012
    57
    April 20, 2012
  15. Click to see all coverage from Apr 21, 2012
    0
    April 21, 2012
  16. Click to see all coverage from Apr 22, 2012
    4
    April 22, 2012
  17. Click to see all coverage from Apr 23, 2012
    15
    April 23, 2012
  18. Click to see all coverage from Apr 24, 2012
    152
    April 24, 2012
  19. Click to see all coverage from Apr 25, 2012
    32
    April 25, 2012
  20. Click to see all coverage from Apr 26, 2012
    21
    April 26, 2012
  21. Click to see all coverage from Apr 27, 2012
    14
    April 27, 2012
  22. Click to see all coverage from Apr 28, 2012
    0
    April 28, 2012
  23. Click to see all coverage from Apr 29, 2012
    2
    April 29, 2012
  24. Click to see all coverage from Apr 30, 2012
    4
    April 30, 2012
  25. Click to see all coverage from May 01, 2012
    5
    May 01, 2012
  26. Click to see all coverage from May 02, 2012
    43
    May 02, 2012
  27. Click to see all coverage from May 03, 2012
    22
    May 03, 2012
  28. Click to see all coverage from May 04, 2012
    4
    May 04, 2012
  29. Click to see all coverage from May 05, 2012
    1
    May 05, 2012
  30. Click to see all coverage from May 06, 2012
    1
    May 06, 2012
  31. Click to see all coverage from May 07, 2012
    21
    May 07, 2012
  32. Click to see all coverage from May 08, 2012
    9
    May 08, 2012
  33. Click to see all coverage from May 09, 2012
    10
    May 09, 2012
  34. Click to see all coverage from May 10, 2012
    24
    May 10, 2012
  35. Click to see all coverage from May 11, 2012
    3
    May 11, 2012
  36. Click to see all coverage from May 12, 2012
    0
    May 12, 2012
  37. Click to see all coverage from May 13, 2012
    0
    May 13, 2012
  38. Click to see all coverage from May 14, 2012
    23
    May 14, 2012
  39. Click to see all coverage from May 15, 2012
    10
    May 15, 2012
  40. Click to see all coverage from May 16, 2012
    6
    May 16, 2012
  41. Click to see all coverage from May 17, 2012
    14
    May 17, 2012
  42. Click to see all coverage from May 18, 2012
    4
    May 18, 2012
  43. Click to see all coverage from May 19, 2012
    0
    May 19, 2012
  44. Click to see all coverage from May 20, 2012
    0
    May 20, 2012
  45. Click to see all coverage from May 21, 2012
    6
    May 21, 2012
  46. Click to see all coverage from May 22, 2012
    1
    May 22, 2012
  47. Click to see all coverage from May 23, 2012
    5
    May 23, 2012
  48. Click to see all coverage from May 24, 2012
    0
    May 24, 2012

Related topics

Connections | Listings
  1. Switzerland Switzerland
  2. Pfizer Inc. Pfizer Inc.
  3. United Kingdom United Kingdom
  4. India India
  5. Canada Canada
  6. Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
  7. AstraZeneca PLC AstraZeneca PLC

Related quotes

  • Previous
  • Next
  • 1/25
  1. The European Commission has approved Signifor (pasireotide) for the treatment of adult patients with Cushing's disease for whom surgery is not an option or for whom surgery has failed
    – Novartis SOURCE: France 24 4 weeks ago
  2. Including the initial acquisition payment plus potential additional regulatory milestone payments, the deal with Novartis could exceed $550 million
    SOURCE: Boston.com 2 weeks ago
  3. It is unacceptable to put the safety of patients at risk through the widespread use of an unlicensed treatment when a licensed medicine is available. It undermines the regulatory process that was introduced to safeguard patients.
    – Novartis SOURCE: PharmaGossip 1 month ago
  4. Fougera and Sandoz serve many of the same customers in the US, creating significant sales and cost synergies with Sandoz's sizeable US generics business ... We welcome the team from Fougera Pharmaceuticals into Sandoz and Novartis.
    SOURCE: World Pharma News 2 weeks ago
  5. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion for Jakavi
    – Novartis SOURCE: Reuters 1 month ago
  6. I don’t think Novartis will lose.
    SOURCE: PharmaGossip 3 weeks ago
  7. The label update in the United States for Gilenya recommends that patients with certain pre-existing cardiac conditions or those taking certain concomitant medications would require overnight monitoring following administration of first dose of medication
    – Novartis SOURCE: Reuters 1 month ago
  8. I think Novartis’s action is absolutely, fundamentally right. There is a National Institute for Health and Clinical Excellence recommendation behind [ranibizumab for wet AMD].
    SOURCE: PharmaGossip 3 weeks ago
  9. However, a contribution of Gilenya to the evolution of this case cannot be excluded.
    – Novartis SOURCE: Bloomberg.com 1 month ago
  10. In contrast, Novartis ('AA'/Stable), Sanofi ('AA-'/ Stable), GlaxoSmithKline ('A+'/Stable) and Bayer ('A-'/Stable) have less headroom within their current ratings to pursue debt-financed investments
    SOURCE: Reuters Mobile 3 weeks ago
  11. The current assessment is that Tysabri is the drug most likely associated with this case of PML ... However, a contribution of Gilenya to the evolution of this case cannot be excluded.
    – Novartis SOURCE: Boston.com 1 month ago
  12. Novartis puts patient safety first and believes Lucentis is the best treatment option for patients with wet AMD ... Novartis believes that, within regulatory guidelines, the unlicensed use of drugs should be limited to cases where there is an unmet medical need which cannot be fulfilled by licensed medi...
    SOURCE: FiercePharma 3 weeks ago
  13. A role for Gilenya can neither be confirmed nor excluded at this time
    – Novartis SOURCE: Bloomberg.com 2 months ago
  14. Even ignoring the U.S. market, NVA looks like a good mid- sized opportunity for Novartis
    SOURCE: Bloomberg.com 3 weeks ago
  15. Some uncertainty is to be expected in the marketplace as some physicians and patients wait for final review and potential label changes ... Overall, we see Gilenya continuing to grow in volume. Gilenya potential is seen as unchanged.
    – Novartis SOURCE: Bloomberg.com 2 months ago
  16. The Afinitor prototype of early studies of a drug in multiple parallel indications will be a common model for Novartis Oncology in the future. ’We would rather start earlier in multiple directions than follow a traditional, sequential approach to development.
    SOURCE: Med City News 3 weeks ago
  17. Price in the case of Glivec is irrelevant
    – Novartis SOURCE: Economic Times 2 months ago
  18. Almost 400 Novartis Egypt team members from the company’s various divisions including Novartis Pharma, Sandoz, OTC and Alcon, today join their colleagues around the world in volunteering their time and effort to contribute to their community’s overall welfare.
    SOURCE: TradeArabia 4 weeks ago
  19. for adults with KIT (CD117)-positive gastrointestinal stromal tumors (GIST)
    – Novartis SOURCE: Yahoo! Health 2 months ago
  20. Corporate responsibility is part of our essence of who we are at Novartis. Today marks our 16th annual Community Partnership Day, an important way in which Novartis lives up to its strong commitment to corporate citizenship
    SOURCE: TradeArabia 4 weeks ago
  21. Corporate responsibility is part of our essence of who we are at Novartis. Today marks our 16th annual Community Partnership Day, an important way in which Novartis lives up to its strong commitment to corporate citizenship
    SOURCE: TradeArabia 4 weeks ago
  22. The extension of our alliance with Novartis confirms the value of the cHTS discovery technology to the advancement of novel treatments for cancer
    SOURCE: Business Wire 4 weeks ago
  23. It was almost 2 million products, basically all the chemicals Novartis has
    SOURCE: Nature.com 4 weeks ago
  24. Companies like Novartis should not be in the position to block moves to more cost-effective treatments in order to maximize their profits
    SOURCE: Reuters.co.uk 1 month ago
  25. We anticipate Glaxo’s product will be highly competitive, packaged in a multidose dry powder inhaler, compared with Novartis’s single-dose inhaler
    SOURCE: Bloomberg.com 1 month ago

Related videos

  1. YouTube
  1. Loading video...
    1. Novartis
      Novartis
      2 months ago
    2. shame novartis management
      shame novartis management
      1 month ago
    3. FDA: Novartis Recall May Also Affect Painkillers
      FDA: Novartis Recall May Also Affect Painkillers
      4 months ago
    4. Novartis drop the case
      Novartis drop the case
      4 weeks ago
    5. Novartis Oncology
      Novartis Oncology
      7 months ago
    6. Novartis
      Novartis
      5 months ago

Newsmap

See the geographical connection between Novartis and different parts of the world. Mouse over the map pins to explore connections.

There are no results for this module.